The Board of Directors
The Board of Directors is the operational management body of the Association. The members of ARSER, at a general meeting, elect its members. Their term of office is three years. The Board of Directors elects its bureau: President, Vice-president, Secretary-General, Treasurer.
The current composition of the Board of Directors is as follows:
President: Professor Sylvie DELANIAN – Vice President: Professor Pierre-François PRADAT – Secretary general: Jean-Bernard FROIDURE – Treasurer: Régine KUBIAK – Responsible for External Relations: Jean-Pierre BRIOT and Roselyne NICOLAS – Delegations: Brittany: Jean VALLEE – Occitania: Hans CARL.
The Bureau of ARSER
Regional and international Delegations
The Scientific Council
A Scientific Council supports the Association at the national level. The Board of Directors chooses the members of the Scientific Council for a term of two years, renewable. The role of the Scientific Council is defined in the rules of procedure.
The current composition of the Scientific Council is the following:
Dr. Sylvie DELANIAN oncologist-Radiotherapist, St. Louis hospital:
It’s a great hope because she is characterized by her relevance to the subject, on the one hand, and her lack of belligerence, i.e. the objective is not to protest or to say “Why me?” …Well, there is the view that it is inevitable, but at the same time, what can we do? That is, this is an ongoing issue. We already have in this association digested the pill of: “too bad, it would have been preferable not to happen; but now that it has happened, what to do?”. Governments handle very well what is upstream, i.e. prevention, making radiation therapy more focused, smarter, more intelligent. But anyway, whatever we do, there will always be a small contingent and this small contingent is composed of people who exist. Behind the scans, there is someone, that someone needs to be helped, and I may be one of the people who can help them.
Dr. Pierre-François PRADAT neurologist, La Pitié-Salpêtrière hospital:
I especially had the good fortune to meet Mr Hervé LIONEL MARIE and to realize that what he could bring to this topic interested me and was absolutely critical and that he could bring elements that I was unable to provide. Then we talked about the research funding; it is true that there is institutional financing, but it is insufficient. Therefore, there is a need for society to come and support. So the role of an association in this context is absolutely essential. Moreover, there is a need to interact with public authorities. And we know that the present evolution is probably a positive evolution and that the contacts for government authorities are no longer doctors but are patient associations. So the era of ministers first consulting powerful doctors is a thing of the past. Therefore, we need people who are affected by the disease but who also have a broader scope than our technical vision, which is necessarily a derivative of medical problems.